Cytokinetics Inc (CYTK.OQ)

CYTK.OQ on NASDAQ Stock Exchange Global Select Market

6.48USD
8 Feb 2016
Change (% chg)

$-0.43 (-6.22%)
Prev Close
$6.91
Open
$6.86
Day's High
$6.87
Day's Low
$6.37
Volume
139,665
Avg. Vol
162,848
52-wk High
$13.15
52-wk Low
$5.50

CYTK.OQ

Chart for CYTK.OQ

About

Cytokinetics, Incorporated is a clinical stage biopharmaceutical company. The Company is focused on the discovery and development of small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. The Company's drug candidates that are in clinical development are its... (more)

Overall

Beta: 1.39
Market Cap(Mil.): $251.73
Shares Outstanding(Mil.): 38.85
Dividend: --
Yield (%): --

Financials

  CYTK.OQ Industry Sector
P/E (TTM): -- 36.97 38.72
EPS (TTM): -0.50 -- --
ROI: -27.12 6.90 14.47
ROE: -28.14 8.97 15.40
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks